These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study. Seibold F; Boldt AB; Seibold-Schmid B; Schoepfer AM; Flogerzi B; Müller S; Kun JF Inflamm Bowel Dis; 2007 Sep; 13(9):1077-82. PubMed ID: 17480019 [TBL] [Abstract][Full Text] [Related]
67. Clinical utility of serological markers in inflammatory bowel disease. Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050 [TBL] [Abstract][Full Text] [Related]
68. A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan. Gaifem J; Rodrigues CS; Petralia F; Alves I; Leite-Gomes E; Cavadas B; Dias AM; Moreira-Barbosa C; Revés J; Laird RM; Novokmet M; Štambuk J; Habazin S; Turhan B; Gümüş ZH; Ungaro R; Torres J; Lauc G; Colombel JF; Porter CK; Pinho SS Nat Immunol; 2024 Sep; 25(9):1692-1703. PubMed ID: 39080486 [TBL] [Abstract][Full Text] [Related]
69. Anti Saccharomyces cerevisiae Antibodies in Patients With Anti-β2 Glycoprotein I Antibodies. Mankaï A; Layouni S; Ghedira I J Clin Lab Anal; 2016 Nov; 30(6):818-822. PubMed ID: 27061484 [TBL] [Abstract][Full Text] [Related]
70. Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch. Tang LY; Cai H; Navaneethan U; Boone JH; Rhodes SJ; Moore L; Rho H; de La Motte C; Queener E; Shen B Int J Colorectal Dis; 2012 Nov; 27(11):1455-63. PubMed ID: 22430887 [TBL] [Abstract][Full Text] [Related]
72. Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. Heelan BT; Allan S; Barnes RM Immunol Lett; 1991 Jun; 28(3):181-5. PubMed ID: 1885214 [TBL] [Abstract][Full Text] [Related]
73. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Aydin SZ; Atagunduz P; Temel M; Bicakcigil M; Tasan D; Direskeneli H Rheumatology (Oxford); 2008 Feb; 47(2):142-4. PubMed ID: 18160421 [TBL] [Abstract][Full Text] [Related]
74. ASCA (Anti-Saccharomyces cerevisiae Antibody) in Patients With Scleroderma. Fedrigo A; Skare TL; Bortoluzzi AL; Nisihara R J Clin Rheumatol; 2019 Jan; 25(1):24-27. PubMed ID: 29561467 [TBL] [Abstract][Full Text] [Related]
75. The effect of dietary yeast on the activity of stable chronic Crohn's disease. Barclay GR; McKenzie H; Pennington J; Parratt D; Pennington CR Scand J Gastroenterol; 1992; 27(3):196-200. PubMed ID: 1502481 [TBL] [Abstract][Full Text] [Related]
76. Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Sakly W; Jeddi M; Ghedira I Dig Dis Sci; 2008 Jul; 53(7):1983-7. PubMed ID: 18049897 [TBL] [Abstract][Full Text] [Related]
79. Frequency of ASCA seropositivity in children with cystic fibrosis. Condino AA; Hoffenberg EJ; Accurso F; Penvari C; Anthony M; Gralla J; O'Connor JA J Pediatr Gastroenterol Nutr; 2005 Jul; 41(1):23-6. PubMed ID: 15990625 [TBL] [Abstract][Full Text] [Related]
80. Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Sakly W; Mankaï A; Sakly N; Thabet Y; Achour A; Ghedira-Besbes L; Jeddi M; Ghedira I Endocr Pathol; 2010 Jun; 21(2):108-14. PubMed ID: 20387011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]